#China #BGM Group #Guilin Pharma #Qilian Pharma #Chengdu

BGM Group Welcomes Guilin Pharma for Partnership Development

On November 19, 2024, a significant development occurred in the pharmaceutical industry when BGM Group Ltd invited a team from Guilin Pharmaceutical Co., Ltd. to participate in an on-site audit. This meeting aimed to explore future collaboration opportunities between the two companies. The audit team comprised experts, including Quality Assurance Engineer Ms. Shen and Technical Manager Ms. An, who were keen to assess Qilianshan Pharmaceutical Co., Ltd. (Qilian Pharma), a prominent subsidiary of BGM Group.

The Importance of the Audit

Guilin Pharma, part of Fosun Pharma, is recognized as a leading pharmaceutical enterprise in Guangxi Province, China. Their expertise extends across various domains, from research and development to the production and sales of chemical drugs. With a diverse portfolio that includes over 200 varieties, such as tablets, capsules, and injections, Guilin Pharma ranks as a top exporter within the region.

During the visit, Mr. Lu, the Executive Deputy General Manager of Qilian Pharma, along with his management team, provided the audit team with a comprehensive overview of their innovative production techniques, product attributes, and competitive edge in the market. They highlighted key areas such as the production workshop and the quality testing center, which were key focal points of the audit.

A Thorough Examination

The team conducted a meticulous review of various facilities, evaluating the production workshop, raw material storage, and quality testing environments. The audit team praised Qilian Pharma for their rigorous production standards and state-of-the-art equipment. They noted the excellent maintenance of machinery and the high cleanliness standards upheld in the production areas. Such diligence not only ensures high-quality products but also reflects the company’s dedication to effective management practices.

Collaborative Improvements

Through open discussions, both parties were able to pinpoint potential enhancements in Qilian Pharma's production processes. Setting clear objectives for product quality and customer service improvements marked a crucial step forward in their ongoing collaboration. This partnership aims to boost customer satisfaction and foster long-term loyalty among consumers.

BGM Group has maintained a steadfast commitment to producing safe and affordable pharmaceutical ingredients, aiming to elevate global healthcare standards. By collaborating with companies like Guilin Pharma, they are positioned to deliver high-quality products that meet the diverse needs of the healthcare sector globally.

About BGM Group Ltd

Based in Chengdu, China, BGM Group Ltd is an innovative leader in the biopharmaceutical industry, focusing on biotechnology, bio-extraction, and medical health solutions. Their product offerings include essential active pharmaceutical ingredients (APIs) like oxytetracycline, along with licorice preparations and crude heparin sodium. The oxytetracycline API serves both human antibiotic manufacturing and the agricultural industry, ensuring safe breeding practices for livestock and fisheries. With a commitment to quality and customer satisfaction, BGM Group is poised to remain a vital player in the global pharmaceutical market.

For more details about BGM Group Ltd, visit their official website: BGM Group Ltd.